“Design, Molecular Docking, Synthesis, Characterization and Preliminary Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Cyclin-Dependent Kinase 2 Inhibitors”, AJPS, vol. 25, no. 1, pp. 94–109, Jan. 2025, doi: 10.32947/ajps.v25i1.1132.